Glynore Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.40 M
- Company Age 24 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.04 Cr
- Revenue Growth 63.46%
- Profit Growth 117.06%
- Ebitda 32.10%
- Net Worth 7.70%
- Total Assets 1.71%
About Glynore Pharma
Glynore Pharma Private Limited (GPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 September 2000 and has a history of 24 years and four months. Its registered office is in Punjab, Punjab.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.40 M.
The company currently has active open charges totaling ₹6.04 Cr.
Harsimran Kaur and Amritpal Singh serve as directors at the Company.
Company Details
- Location Punjab, Punjab
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232PB2000PTC023961
-
Company No.
023961
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Sep 2000
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Glynore Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harsimran Kaur
|
Director | 14-Dec-2015 | Current |
|
Amritpal Singh
|
Director | 15-Sep-2000 | Current |
Financial Performance of Glynore Pharma.
Glynore Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.46% increase. The company also saw a substantial improvement in profitability, with a 117.06% increase in profit. The company's net worth moved up by a moderate rise of 7.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Glynore Pharma?
In 2023, Glynore Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ds Cosmeceuticals Private LimitedHarsimran Kaur is a mutual person
Charges (Loans)
₹60.38 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 3.99 Cr
- Hdb Financial Services Limited : 1.25 Cr
- Centurian Bank Of Punjab Limited : 0.50 Cr
- Centurian Bank Limited : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2023 | Hdfc Bank Limited | ₹1.55 M | Open |
| 10 Nov 2020 | Hdfc Bank Limited | ₹2.51 M | Open |
| 26 Dec 2016 | Hdfc Bank Limited | ₹2.48 Cr | Open |
| 30 Apr 2015 | Hdb Financial Services Limited | ₹1.25 Cr | Open |
| 16 Apr 2005 | Centurian Bank Limited | ₹3.00 M | Open |
How Many Employees Work at Glynore Pharma?
Unlock and access historical data on people associated with Glynore Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Glynore Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glynore Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
